Wednesday 3rd March 2021 | MIKE SMITH
Spain will be receiving an additional 17 million doses of COVID-19 vaccines from Moderna for distribution among the autonomous communities during the second half of the year.
The Council of Ministers approved Spain’s support of the authorization agreement to comply with the provisions of the new negotiating process with the company undertaken by the European Commission to formalize the Acquisition Agreement (AP) of 150 million additional doses of the vaccine.
According to the distribution to the participating member states, Spain is entitled to 17 million doses, at a rate of 5,666,667 doses in the third quarter and 11,333,333 in the fourth quarter of 2021. This Acquisition Agreement contemplates the possibility of purchase of vaccines against the new variants of the SARS-COV2 virus.
This agreement, which also includes the possibility of opting for another 150 million optional doses in the future, succeeds in time the Advance Purchase Agreement (APA) signed on December 4 between the European Commission and Moderna for the development and supply of an effective vaccine against COVID, consisting of 160 million doses, at a rate of 80 million initial and 80 million additional.
Thus, the Spanish Government has approved the authorization agreement to adequately comply with the provisions of the Commission Decision of June 18, 2020, which approves the agreement with the member states for the acquisition of vaccines against COVID and the concretion in new purchase agreement with Moderna.
Press Release – Ministerio de Sanidad